- Home
- DKL vs CLDX Comparison
DKL vs CLDX Comparison
Compare DKL & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | DKL | CLDX |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Natural Gas Distribution | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.6B |
| IPO Year | 2012 | 1995 |
Fundamental Metrics
Financial Performance| Metric | DKL | CLDX |
|---|---|---|
| Price | $58.30 | $43.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $53.67 | $46.60 |
| AVG Volume (30 Days) | 73.1K | ★ 929.5K |
| Earning Date | 04-29-2026 | 05-04-2026 |
| Dividend Yield | ★ 8.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $12,743,000.00 |
| Revenue This Year | $2.73 | $111.39 |
| Revenue Next Year | $6.82 | $235.85 |
| P/E Ratio | $17.62 | ★ N/A |
| Revenue Growth | N/A | ★ 87.78 |
| 52 Week Low | $41.90 | $20.19 |
| 52 Week High | $61.50 | $42.92 |
Technical Indicators
Market Signals| Indicator | DKL | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 57.27 | 74.14 |
| Support Level | $48.32 | $28.51 |
| Resistance Level | $61.50 | N/A |
| Average True Range (ATR) | 2.29 | 1.61 |
| MACD | -0.19 | 0.54 |
| Stochastic Oscillator | 55.47 | 98.32 |
Price Performance
Historical ComparisonAbout DKL Delek Logistics Partners
Delek Logistics Partners LP owns and operates logistics and marketing assets for crude oil and intermediate and refined products. The company's segment includes gathering and processing; wholesale marketing and terminalling; storage and transportation and investment in pipeline joint ventures. It generates maximum revenue from the wholesale marketing and terminalling segment, which provides marketing services for the refined products output of the Delek Holdings' refineries, engages in wholesale activity at its terminals and terminals owned by third parties, whereby it purchases light product for sale and exchange to third parties, and provides terminalling services at its refined products terminals to independent third parties and Delek Holdings.
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.